1 day Ago By ABMN Staff
Craig Hallum upgraded shares of Green Thumb Industries ( OTCMKTS:GTBIF – Free Report ) to a strong-buy rating in a research note published on Monday morning, Zacks.com reports. Separately, Ventum Cap Mkts raised Green Thumb Industries to a strong-buy rating in a report on Tuesday, August 6th.
Three equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Buy and a consensus target price of $16.
50. Get Our Latest Research Report on GTBIF Green Thumb Industries Trading Down 2.4 % Green Thumb Industries ( OTCMKTS:GTBIF – Get Free Report ) last issued its quarterly earnings data on Monday, August 5th.
The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.
03. The business had revenue of $280.15 million during the quarter, compared to the consensus estimate of $277.
01 million. Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.
39%. On average, equities analysts forecast that Green Thumb Industries will post 0.32 EPS for the current year.
About Green Thumb Industries ( Get Free Report ) Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Featured Stories Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter ..
